Positron emission tomography
"What is an FDG-PET/CT?"
PET/CT is a combined examination procedure consisting of positron emission tomography (PET) and computer tomography (CT) and provides information about metabolic processes taking place in the body on the one hand and, on the other, information about possible pathological changes (e.g. malignant tumors/metastases) in organs and tissue structures by generating high-resolution sectional images.
As part of the FDG PET examination, the patient is first administered a low-level radioactive tracer via a venous access. This is glucose (F-18 fluorodeoxyglucose; FDG) labeled with a radioactive fluorine isotope (fluorine-18). As most malignant tumors have a higher metabolism than healthy tissue and therefore absorb more of this radioactively labeled glucose, this procedure is suitable for differentiating between benign and malignant tumors (e.g. unclear round lung tumor), for searching for an unclear primary tumor, for staging a known tumor or for checking a response to therapy in the case of a known tumor.